Evidence map›Paper›PMID 39757227›Full record

ArticleJournal of cardiothoracic surgery2025

Retrograde thoracic duct embolization in an idiopathic case of chylopericardium.

Renata Kiri Mak, Hon Shing Fung, Tak Kwong Chan, Hoi Leong Chum

Abstract readCase Reports
In one paragraph

Article in Journal of cardiothoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Renata Kiri MakDepartment of Diagnostic and Interventional Radiology, Queen Elizabeth Hospital, King's Park, Hong Kong. renatamak@outlook.com.
Hon Shing FungDepartment of Diagnostic and Interventional Radiology, Queen Elizabeth Hospital, King's Park, Hong Kong.
Tak Kwong ChanDepartment of Nuclear Medicine, Queen Elizabeth Hospital, King's Park, Hong Kong.
Hoi Leong ChumDepartment of Cardiothoracic Surgery, Queen Elizabeth Hospital, King's Park, Hong Kong.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This is a novel case of idiopathic chylopericardium and chylothorax in a young male who had no significant medical history. He first presented with dyspnea due to idiopathic chylopericardium, which was refractory to medical and surgical treatments, including a medium-chain triglyceride diet, octreotide, and video-assisted pericardial window. The chylopericardium persisted and progressed to concomitant left-sided chylothorax. He subsequently underwent multiple imaging studies, including lymphoscintigraphy and an intranodal lymphangiogram, both of which confirmed leakage in the thoracic duct. Finally, thoracic duct embolization was performed via a retrograde transvenous approach, which was successful, with good results. Although idiopathic chylopericardium and chylothorax are extremely rare, it can greatly impact patient quality of life if left undiagnosed and untreated. While surgery can relieve cardiac tamponade, lymphatic imaging and intervention are key in diagnosing and treating the root cause of the condition. This case highlights the importance of multidisciplinary efforts in managing rare cases and how interventional radiology is a minimally invasive but effective way to treat thoracic duct leakage. Retrograde thoracic duct embolization is technically challenging but safe and effective.

Indexed as

ChylothoraxEmbolization, TherapeuticPericardial EffusionThoracic DuctAdultHumansLymphographyMaleChylopericardiumChylothoraxIntranodal lymphangiogramLymphoscintigraphyRetrogradeThoracic duct embolizationThoracic duct leakage

Identifiers

PMID39757227
PMCPMC11702016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.